📊 Score Breakdown
Offering Ability
60
Cash Runway
65
Float Risk
12
Warrant Exposure
30
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
50%
🔄 Reverse Split
65%
• 50-day avg $0.78 below $1 exchange minimum
• 11 months cash with weak price
📉 Score Deterioration
50%
• Score rose 42 points recently (worsening)
• Score in HIGH risk zone (61/100)
💰 Capital Raise
15%
• Under 12 months cash (11mo)
💹 Market Data
Market Cap$14.92M
Shares Outstanding24.79M
Float23.44M
Cash$5.27M
Debt$94.4K
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 1.9% shares (2025Q4 vs prior)
21 institutional holders · 1.70M shares
#1
Invenomic Capital Management LP
470.9K shares
#2
UBS Group AG
361.3K shares
#3
VANGUARD GROUP INC
258.8K shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest381.9K
Days to Cover2.5
% of Float1.6%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Feb 28, 2026
xbrl
XBRL CONVERTIBLE
Aug 31, 2017
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for LEXX
📊 LEXX FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 LEXX Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.